The PD-L1 tumor proportion score (TPS) with the 22C3 assay was calculated in 46 patients; 17 of them had a PD-L1 TPS < 1%, and 11 of them had a PD-L1 TPS ≥ 50%. Here, CD274 is linked to neoplasm.